FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells

BACKGROUND: Cervical cancer is one of the most common causes of cancer‐associated mortality among affected women in the world. At present, treatment with weekly cisplatin plus ionizing radiation (IR) therapy is the standard regimen for cervical cancer, especially for locally advanced cervical cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Li, Jin‐Li, Wang, Jian‐Ping, Chang, Hong, Deng, Sheng‐Ming, Du, Jia‐Hui, Wang, Xiao‐Xiao, Hu, He‐Juan, Li, Dong‐Yin, Xu, Xiang‐Bin, Guo, Wei‐Qiang, Song, Yao‐Hua, Guo, Zhigang, Sun, Min‐Xuan, Wu, Yi‐Wei, Liu, Song‐Bai
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Cancer Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912068/
https://ncbi.nlm.nih.gov/pubmed/31670906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars